Supports integration of screening tools into the electronic health record (EHR) by documenting findings that inclusion of the Drug Abuse Screening Test into the EHR increased both screenings and provider intervention for positive screenings
Discusses how the COVID-19 pandemic has challenged implementation of screening and brief intervention, and identifies potential opportunities to use SBI to further identify and treat substance use disorders
Describes why SBIRT for substance use and behavioral health is particularly important in the era of COVID-19, describing its cost-effectiveness and return on investment
A pilot, non-inferiority study designed to see if Remote Brief Intervention and Referral to Treatment is just as successful at lowering drinking as SBIRT, while increasing the number of patients seen, decreasing costs, and maintaining efficacy of the intervention
Evaluates a new AAPPQ that uses person-centered language and addresses the spectrum of alcohol use, concluding that the 30-item instrument is a promising tool for assessing providers' attitudes toward unhealthy alcohol use without promoting negative biases
Identifies four steps that will help to ensure that a broader transition to telehealth will be successful in improving the health outcomes of patients with substance use disorders
Systematic review to evaluate the measures of effectiveness, efficiency, and quality that result from the utilization of telemedicine in the management of alcohol abuse, addiction, and rehabilitation